Stable oncolytic formulations

Details Stable oncolytic formulations Stable oncolytic formulations

Filed on

1984-10-10

Date issued

1986-10-28

Examiner

Goldberg, Jerome D.

Patent Class

Drug, bio-affecting and body treating compositions

SubClass

Designated organic active ingredient containing

SubSubClass

Having -c-, wherein x is chalcogen, bonded directly to...

Other Related Categories

A61K 3144

Type

Patent

Status

active

Patent number

046199357

Description

ABSTRACT:
Stable, sterile, ready-to-use formulations of oncolytic vincristine are provided.

REFERENCES:
patent: 3097137 (1963-07-01), Beer et al.
patent: 3205220 (1965-09-01), Svoboda et al.
patent: 3749784 (1973-07-01), Johnson
patent: 4188394 (1980-02-01), Eakins et al.
patent: 4190673 (1980-02-01), Eakins et al.
patent: 4203898 (1980-05-01), Cullinan et al.
patent: 4208414 (1980-06-01), Schinitsky
patent: 4259242 (1981-03-01), Rolski
patent: 4310528 (1982-01-01), Jovanovics et al.
"Remington's Pharmaceutical Sciences" Mack Publishing Co. (Easton, Pa.) pp. 229-243 (1980).
"Manual of Oncology Therapeutics", The C. V. Mosby Co., Publisher, pp. 212-214 (1981).
Physicians' Desk Reference, 36th Edition (1982), pp. 1129-1130.
Physicians' Desk Reference, 36th Edition (1982), pp. 1142-1144.
APhA Academy of Pharmaceutical Sciences, 129th APhA Annual Meeting, Las Vegas, Nev., 4/24-29/82, vol. 12, No. 1, Abstract No. 15 (Basic Pharmaceuticals Sec., p. 41).
APhA Academy of Pharmaceutical Sciences, 129th APhA Annual Meeting, Las Vegas, Nev., 4/24-29/82, vol. 12, No. 1, Abstract No. 7, (Pharm. Analysis & Control Sec., p. 79).
J. H. Burns in Analytical Profiles of Drug Substances, vol. 1, Academic Press (New York and London, 1972), pp. 463-480.

Affiliated with

Also associated with

Rating

Stable oncolytic formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable oncolytic formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable oncolytic formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1346690